Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments
datasetposted on 10.04.2018, 00:00 authored by Stefania Ferro, Batel Deri, Maria Paola Germanò, Rosaria Gitto, Laura Ielo, Maria Rosa Buemi, Giovanna Certo, Serena Vittorio, Antonio Rapisarda, Yael Pazy, Ayelet Fishman, Laura De Luca
The inhibition of tyrosinase (Ty, EC 126.96.36.199) represents an efficient strategy of decreasing melanogenesis and skin hyperpigmentation. A combination of crystallographic and docking studies on two different tyrosinases, that from Bacillus megaterium (TyBm) and that from a mushroom (TyM), has contributed to increasing our knowledge about their structural information and translating that information to the most druggable human Ty (TyH) isozyme. In particular, we designed and synthesized a series of 1-(4-fluorobenzyl)piperazine and 1-(4-fluorobenzyl)piperidine derivatives showing inhibitory activities on TyM at micromolar ranges and more potency than that of the reference compound, kojic acid. The crystal structures of TyBm with inhibitor 3 (IC50 value of 25.11 μM) and 16 (IC50 value of 5.25 μM) were solved, confirming the binding poses hypothesized by in silico studies and revealing the main molecular determinants for the binding recognition of the inhibitors.
Read the peer-reviewed publication
TyMseriesfluorobenzylTyBm5.25 μ MtyrosinaseTyHcrystal structuresdocking studiesmelanogenesimushroomisozymesilico studiesstrategyderivativedeterminantdruggable25.11 μ McombinationinformationECreference compoundinhibitionpotencykojic acidBacillus megateriuminhibitor 3Novel Inhibitors Bearing ArylpiperidineIC 50 valuebinding recognitionTargeting TyrosinaseStructural InsightsArylpiperazine Fragmentsskin hyperpigmentationmicromolar ranges